PTEN and pancreatic adenocarcinoma: Notably, using the cBioportal website, we analyzed 1034 pancreatic adenocarcinoma samples in five cohorts, and noticed that in PDAC, only 0.9% samples had PTEN deletion or mutation (https://www.cbioportal.org/).